Literature DB >> 10541360

Growth and characterization of LNCaP prostate cancer cell spheroids.

A M Ballangrud1, W H Yang, A Dnistrian, N M Lampen, G Sgouros.   

Abstract

Cells from the prostate tumor cell line LNCaP have been grown as spheroids. The growth kinetics of the spheroids have been characterized by fitting a Gompertz equation to spheroid growth curves. The proliferation state of cells within spheroids of different diameters was assessed by bromodeoxyuridine staining. Scanning and electron transmission microscopy were performed to determine the ultrastructure of the spheroids. Prostate-specific antigen (PSA) secretion was monitored throughout spheroid growth. Consistent with Gompertzian kinetics, the volume of LNCaP spheroids initially increased exponentially and then reached a plateau. The doubling time during the exponential phase was 29 +/- 4 h. A core of nonproliferating cells was seen in spheroids with a diameter of 400 microm; at a diameter of 600 microm, a necrotic core had formed. In smaller, 200-microm diameter spheroids, a core of nonproliferating cells was not seen, but proliferating cells were concentrated at the spheroid periphery. Electron microscopy showed that the spheroids were enveloped by an extracellular matrix and that cell adhesion within the spheroids was due in part to desmosomes. PSA secretion by the spheroids could be modeled as originating from a spherical shell whose thickness was independent of overall spheroid diameter. The shell thickness obtained by fitting an appropriate equation to the data was consistent with that determined from the bromodeoxyuridine studies. LNCaP cells exhibit several important features of prostate cancer cells; in vivo, they are androgen responsive, and they express prostatic acid phosphatase, PSA, and prostate-specific membrane antigen. LNCaP spheroids provide a simple but relevant model for the study of drug delivery and response in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541360

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

1.  Self-Assembling Peptide Gels for 3D Prostate Cancer Spheroid Culture.

Authors:  Kelly M Hainline; Fangqi Gu; Jacqueline F Handley; Ye F Tian; Yaoying Wu; Larischa de Wet; Donald J Vander Griend; Joel H Collier
Journal:  Macromol Biosci       Date:  2018-10-15       Impact factor: 4.979

Review 2.  Liquid-based three-dimensional tumor models for cancer research and drug discovery.

Authors:  Stephanie L Ham; Ramila Joshi; Pradip S Thakuri; Hossein Tavana
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-11

3.  3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer.

Authors:  Karen F Chambers; Eman M O Mosaad; Pamela J Russell; Judith A Clements; Michael R Doran
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

4.  Tumour-induced neoneurogenesis and perineural tumour growth: a mathematical approach.

Authors:  Georgios Lolas; Arianna Bianchi; Konstantinos N Syrigos
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

Review 5.  Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.

Authors:  Fabrizio Fontana; Michela Raimondi; Monica Marzagalli; Michele Sommariva; Nicoletta Gagliano; Patrizia Limonta
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

6.  Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms.

Authors:  Josiah Ochieng; Olga Y Korolkova; Guoliang Li; Renjie Jin; Zhenbang Chen; Robert J Matusik; Samuel Adunyah; Amos M Sakwe; Olugbemiga Ogunkua
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

7.  Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment.

Authors:  Shirly Sieh; Anna V Taubenberger; Simone C Rizzi; Martin Sadowski; Melanie L Lehman; Anja Rockstroh; Jiyuan An; Judith A Clements; Colleen C Nelson; Dietmar W Hutmacher
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

8.  A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development.

Authors:  Yvonne K Girard; Chunyan Wang; Sowndharya Ravi; Mark C Howell; Jaya Mallela; Mahmoud Alibrahim; Ryan Green; Gary Hellermann; Shyam S Mohapatra; Subhra Mohapatra
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs.

Authors:  Mathias Tesson; Colin Rae; Colin Nixon; John W Babich; Robert J Mairs
Journal:  J Pharm Pharmacol       Date:  2016-05-03       Impact factor: 3.765

10.  An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma.

Authors:  Mathias Tesson; Richa Vasan; Andreas Hock; Colin Nixon; Colin Rae; Mark Gaze; Robert Mairs
Journal:  Oncotarget       Date:  2018-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.